Clinical Research Directory
Browse clinical research sites, groups, and studies.
EDRN Prostate MRI Biomarker Study
Sponsor: University of Michigan
Summary
The commercialization of MRI fusion biopsies has resulted in a dramatic increase in the use of MRI imaging for prostate cancer. How best to use MRI in the initial prostate biopsy setting given the availability of validated prostate cancer early detection markers is uncertain.This study will allow investigators to determine if prostate MRI is superior to validated panel of laboratory biomarkers (e.g. PCA3, PSA and TMPRSS2:ERG) in the initial biopsy setting.
Official title: EDRN Prostate MRI Biomarker Study and Reference Set
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
950
Start Date
2019-02-04
Completion Date
2028-12-31
Last Updated
2026-01-08
Healthy Volunteers
No
Conditions
Interventions
MRI prostate
MRI and laboratory biomarkers
Locations (1)
University of Michigan
Ann Arbor, Michigan, United States